dacarbazine has been researched along with Thyroid Neoplasms in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.52) | 18.7374 |
1990's | 5 (23.81) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 7 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benna, NE; Bennani, N; Fares, S; Hadri, H; Karkouri, M; Lembarki, G; Moussali, N; Moutiqui, T; Naoumi, S; Quessar, A; Regragui, M | 1 |
Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB | 1 |
Borson-Chazot, F; Bournaud, C; Decaussin-Petrucci, M; Descotes, F; Joly, MO; Lapras, V; Marchand, L; Nozières, C; Walter, T | 1 |
de Juan, M; Díaz, R; Fonfría, M; Mancheño, N; Moral, P; Tormo, A | 1 |
Deutschbein, T; Lahner, H; Mann, K; Matuszczyk, A; Moeller, LC; Petersenn, S; Unger, N; Yuece, A | 1 |
Licitra, L; Locati, LD | 1 |
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D | 1 |
Hamilton, G; Kaczirek, K; Mittlböck, M; Niederle, B; Passler, C; Pfragner, R; Prager, G; Raderer, M; Scheuba, C; Schindl, M; Siegl, V; Weinhäusel, A | 1 |
Goldenberg, DM; Stein, R | 1 |
Moley, JF; Quayle, FJ | 1 |
Clarke, PM; Sandison, A; Tysome, JR | 1 |
Dunder, K; Ekeblad, S; Eriksson, B; Granberg, D; Janson, ET; Kindmark, H; Kozlovacki, G; Oberg, K; Orlefors, H; Sigurd, M; Skogseid, B; Sundin, A; Welin, S | 1 |
Foley, JF; Kessinger, A; Lemon, HM | 1 |
Abdelmoumene, N; Couette, JE; Delisle, MJ; Schlumberger, M | 1 |
Angeli, A; Berruti, A; Caraci, P; Dogliotti, L; Orlandi, F; Pivano, G; Puligheddu, B | 1 |
Averbuch, SD; Ball, DW; Baylin, SB; de Bustros, A; McGuire, WP; Wu, LT | 1 |
Becker, W; Behr, TM; Blumenthal, RD; Dunn, RM; Gratz, S; Radetzky, S; Raue, F; Rave-Fränk, M; Schmidberger, H; Wulst, E | 1 |
Baudin, E; Cailleux, AF; Mechelany-Corone, C; Nocera, M; Pellegriti, G; Schlumberger, M | 1 |
Chen, S; Goldenberg, DM; Reed, L; Richel, H; Stein, R | 1 |
Barth, V; Schönfelder, M | 1 |
Petursson, SR | 1 |
2 review(s) available for dacarbazine and Thyroid Neoplasms
Article | Year |
---|---|
Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Endocrine Surgical Procedures; Fluorouracil; Humans; Lymph Node Excision; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Parathyroidectomy; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Thyroidectomy; Transplantation, Autologous | 2005 |
Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Doxorubicin; Humans; Ifosfamide; Liposarcoma, Myxoid; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Thigh; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2006 |
4 trial(s) available for dacarbazine and Thyroid Neoplasms
Article | Year |
---|---|
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Radiotherapy, Adjuvant; Streptozocin; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 1995 |
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Dacarbazine; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Thyroid Neoplasms | 1994 |
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Thyroid Neoplasms; Vincristine | 1994 |
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Streptozocin; Thyroid Neoplasms; Treatment Outcome | 2000 |
15 other study(ies) available for dacarbazine and Thyroid Neoplasms
Article | Year |
---|---|
[Primary hodgkin lymphoma of thyroid: case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Middle Aged; Thyroid Neoplasms; Thyroidectomy; Vinblastine | 2017 |
Thyroid malignancies in survivors of Hodgkin lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Databases, Factual; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Poisson Distribution; Prednisone; Procarbazine; Radiotherapy Dosage; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Survivors; Thyroid Neoplasms; Vinblastine; Vincristine; Young Adult | 2014 |
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Fluorouracil; Humans; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Treatment Outcome; Tumor Suppressor Proteins | 2016 |
Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.
Topics: Adenocarcinoma, Follicular; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Esophageal Neoplasms; Esophagectomy; Female; Humans; Hypertension; Immunotherapy; Interferons; Melanoma; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Thyroid Neoplasms | 2010 |
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma; Carcinoma, Neuroendocrine; Cohort Studies; Cyclophosphamide; Dacarbazine; Female; Gastrointestinal Tract; Hospitals, University; Humans; Male; Middle Aged; Myelopoiesis; Neoplasm Staging; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Tumor Burden; Vincristine | 2011 |
Multikinase inhibitors in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Clinical Trials as Topic; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Iodine Isotopes; Molecular Targeted Therapy; Multiple Endocrine Neoplasia Type 2a; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms | 2012 |
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Medullary; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Humans; Paclitaxel; Thyroid Neoplasms | 2004 |
A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Dacarbazine; Humans; Mice; Mice, Nude; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
Topics: Aged; Bronchial Neoplasms; Carcinoid Tumor; Dacarbazine; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Temozolomide; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Therapy of malignant APUD cell tumors. Effectiveness of DTIC.
Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Dacarbazine; Female; Humans; Ileal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Thyroid Neoplasms | 1983 |
Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Immunoglobulin G; Iodine Radioisotopes; Mice; Mice, Nude; Radioimmunotherapy; Radionuclide Imaging; Streptozocin; Thyroid Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Female; Mice; Mice, Nude; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2002 |
[Study of procreation capacity of men after treatment of their malignant tumors (melanoblastoma, thyroid carcinoma) with ionizing radiation and cytostatic agents].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cobalt Radioisotopes; Cyclophosphamide; Dacarbazine; Fertility; Fluorouracil; Humans; Male; Melanoma; Methotrexate; Radiotherapy Dosage; Sperm Count; Sperm Motility; Spermatozoa; Thyroid Neoplasms | 1990 |
Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apudoma; Carcinoma; Dacarbazine; Female; Fluorouracil; Humans; Thyroid Neoplasms | 1988 |